Smad3	O
activates	O
the	O
Sox9	O
-	O
dependent	O
transcription	O
on	O
chromatin	O
.	O


Transforming	O
growth	O
factor	O
(	O
TGF	O
)	O
-	O
beta	O
has	O
an	O
essential	O
role	O
for	O
the	O
Sry	O
-	O
type	O
high	O
-	O
mobility	O
-	O
group	O
box	O
(	O
Sox	O
)	O
-	O
regulated	O
chondrogenesis	O
.	O


Chondrogenic	O
differentiation	O
is	O
also	O
controlled	O
by	O
chromatin	O
-	O
mediated	O
transcription	O
.	O


We	O
have	O
previously	O
reported	O
that	O
TGF	O
-	O
beta	O
-	O
regulated	O
Smad3	O
induces	O
chondrogenesis	O
through	O
the	O
activation	O
of	O
Sox9	O
-	O
dependent	O
transcription	O
.	O


However	O
,	O
the	O
cross	O
-	O
talk	O
between	O
TGF	O
-	O
beta	O
signal	O
and	O
Sox9	O
on	O
chromatin	O
-	O
mediated	O
transcription	O
has	O
not	O
been	O
elucidated	O
.	O


In	O
the	O
present	O
study	O
,	O
we	O
investigated	O
the	O
activity	O
of	O
Smad3	O
,	O
Sox9	O
,	O
and	O
coactivator	O
p300	O
using	O
an	O
in	O
vitro	O
chromatin	O
assembly	O
model	O
.	O


Luciferase	O
reporter	O
assays	O
revealed	O
that	O
Smad3	O
stimulated	O
the	O
Sox9	O
-	O
mediated	O
transcription	O
in	O
a	O
TGF	O
-	O
beta	O
-	O
dependent	O
manner	O
.	O


Recombinant	O
Sox9	O
associated	O
with	O
phosphorylated	O
Smad3	O
/	O
4	O
and	O
recognized	O
the	O
enhancer	B-ENHANCER
region	I-ENHANCER
of	I-ENHANCER
type	I-ENHANCER
II	I-ENHANCER
collagen	I-ENHANCER
gene	E-ENHANCER
.	O


In	O
vitro	O
transcription	O
and	O
S1	O
nuclease	O
assays	O
showed	O
that	O
Smad3	O
and	O
p300	O
cooperatively	O
activated	O
the	O
Sox9	O
-	O
dependent	O
transcription	O
on	O
chromatin	O
template	O
.	O


The	O
combination	O
treatment	O
of	O
phosphorylated	O
Smad3	O
,	O
Sox9	O
,	O
and	O
p300	O
were	O
necessary	O
for	O
the	O
activation	O
of	O
chromatin	O
-	O
mediated	O
transcription	O
.	O


These	O
findings	O
suggest	O
that	O
TGF	O
-	O
beta	O
signal	O
Smad3	O
plays	O
a	O
key	O
role	O
for	O
chromatin	O
remodeling	O
to	O
induce	O
chondrogenesis	O
via	O
its	O
association	O
with	O
Sox9	O
.	O
